| Aktie | Ticker | Breite | GCS | 2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 11.136.250.185 $ | +2.342.245.194 $ | +50,3 % | 26 | 10.164.789.055 $ | +783.454.858 $ | +0,2 % | 30 | 9.918.323.432 $ | +3.066.093.722 $ | +34,3 % | 32 | 7.736.501.045 $ | +2.103.089.588 $ | +57,0 % | 30 | ||||
| UNITED THERAPEUTICS Corp | UTHR | → 0 | Neutral | 1.505.082.912 $ | -64.750.488 $ | -4,1 % | 1 | 1.569.833.400 $ | +300.030.665 $ | +23,6 % | 1 | 1.269.802.735 $ | +417.627.050 $ | +49,0 % | 1 | 852.175.685 $ | +171.156.185 $ | +25,1 % | 1 |
| Ascendis Pharma A/S | ASND | → 0 | 1.363.235.526 $ | +205.289.901 $ | +17,7 % | 1 | 1.157.945.625 $ | +67.427.315 $ | +6,2 % | 1 | 1.090.518.310 $ | +74.599.210 $ | +7,3 % | 1 | 1.015.919.100 $ | +156.371.100 $ | +18,2 % | 1 | |
| Krystal Biotech, Inc. | KRYS | → 0 | Stark | 1.073.713.003 $ | +327.455.455 $ | +43,9 % | 1 | 746.257.548 $ | +34.031.100 $ | +4,8 % | 1 | 712.226.448 $ | +221.865.474 $ | +45,2 % | 1 | 490.360.974 $ | +124.717.374 $ | +34,1 % | 1 |
| MADRIGAL PHARMACEUTICALS, INC. | MDGL | → 0 | Sehr schwach | 984.408.154 $ | +32.644.946 $ | +3,4 % | 1 | 951.763.208 $ | -100.816.342 $ | -9,6 % | 1 | 1.052.579.550 $ | +211.855.770 $ | +25,2 % | 1 | 840.723.780 $ | +273.273.780 $ | +48,2 % | 1 |
| ARGENX SE | ARGX | → 0 | Schwach | 927.770.000 $ | +197.520.000 $ | +27,0 % | 1 | 730.250.000 $ | -102.290.500 $ | -12,3 % | 1 | 832.540.500 $ | +102.356.100 $ | +14,0 % | 1 | 730.184.400 $ | +82.500.900 $ | +12,7 % | 1 |
| ARROWHEAD PHARMACEUTICALS, INC. | ARWR | → 0 | Neutral | 925.591.288 $ | +254.701.351 $ | +38,0 % | 1 | 670.889.937 $ | -34.503.813 $ | -4,9 % | 1 | 705.393.750 $ | +329.452.750 $ | +87,6 % | 1 | 375.941.000 $ | +208.461.000 $ | +124,5 % | 1 |
| Kymera Therapeutics, Inc. | KYMR | → 0 | Neutral | 857.129.238 $ | +234.557.560 $ | +37,7 % | 1 | 622.571.678 $ | +40.961.614 $ | +7,0 % | 1 | 581.610.064 $ | +222.200.064 $ | +61,8 % | 1 | 359.410.000 $ | +73.325.580 $ | +25,6 % | 1 |
| Apellis Pharmaceuticals, Inc. | APLS | → 0 | 491.699.991 $ | +184.677.774 $ | +60,2 % | 1 | 307.022.217 $ | +30.433.333 $ | +11,0 % | 1 | 276.588.884 $ | +65.022.221 $ | +30,7 % | 1 | |||||
| Structure Therapeutics Inc. | GPCR | → 0 | Neutral | 351.836.637 $ | +35.858.886 $ | +11,3 % | 1 | 315.977.751 $ | -139.961.099 $ | -30,7 % | 1 | 455.938.850 $ | +309.345.810 $ | +211,0 % | 1 | 146.593.040 $ | +146.593.040 $ | 1 | |
| Centessa Pharmaceuticals plc | CNTA | → 0 | 454.017.673 $ | +89.983.242 $ | +24,7 % | 1 | 364.034.431 $ | +101.938.491 $ | +38,9 % | 1 | 262.095.940 $ | +196.395.940 $ | +298,9 % | 1 | |||||
| Revolution Medicines, Inc. | RVMD | → 0 | Neutral | 430.182.160 $ | +202.184.981 $ | +88,7 % | 1 | 227.997.179 $ | +55.156.679 $ | +31,9 % | 1 | 172.840.500 $ | +172.840.500 $ | 1 | |||||
| CYTOKINETICS INC | CYTK | → 0 | Neutral | 425.949.915 $ | +206.249.937 $ | +93,9 % | 1 | 219.699.978 $ | +219.699.978 $ | 1 | |||||||||
| Avidity Biosciences, Inc. | RNA | → 0 | 393.469.150 $ | +60.376.500 $ | +18,1 % | 1 | 333.092.650 $ | +132.872.650 $ | +66,4 % | 1 | |||||||||
| Celcuity Inc. | CELC | → 0 | Neutral | 355.708.000 $ | -32.564.500 $ | -8,4 % | 1 | 388.272.500 $ | +77.970.289 $ | +25,1 % | 1 | 310.302.211 $ | +310.302.211 $ | 1 | |||||
| Xenon Pharmaceuticals Inc. | XENE | → 0 | Neutral | 348.746.620 $ | +12.768.887 $ | +3,8 % | 1 | 335.977.733 $ | +92.854.153 $ | +38,2 % | 1 | 243.123.580 $ | +26.313.580 $ | +12,1 % | 1 | 216.810.000 $ | +47.790.000 $ | +28,3 % | 1 |
| Definium Therapeutics, Inc. | DFTX | → 0 | Stark | 338.165.292 $ | +243.665.292 $ | +257,8 % | 1 | 94.500.000 $ | +27.550.000 $ | +41,2 % | 1 | 66.950.000 $ | +66.950.000 $ | 1 | |||||
| Merus N.V. | → 0 | 333.526.375 $ | +167.544.182 $ | +100,9 % | 1 | ||||||||||||||
| uniQure N.V. | QURE | → 0 | Neutral | 309.881.409 $ | +212.442.031 $ | +218,0 % | 1 | 97.439.378 $ | -49.730.122 $ | -33,8 % | 1 | 147.169.500 $ | -112.252.696 $ | -43,3 % | 1 | 259.422.196 $ | +208.889.696 $ | +413,4 % | 1 |
| Terns Pharmaceuticals, Inc. | TERN | → 0 | 300.240.400 $ | +124.500.400 $ | +70,8 % | 1 | 175.740.000 $ | +175.740.000 $ | 1 | ||||||||||
| Vera Therapeutics, Inc. | VERA | → 0 | Neutral | 245.612.034 $ | +8.702.070 $ | +3,7 % | 1 | 236.909.964 $ | -61.303.324 $ | -20,6 % | 1 | 298.213.288 $ | +117.750.688 $ | +65,2 % | 1 | 180.462.600 $ | +32.034.600 $ | +21,6 % | 1 |
| Akero Therapeutics, Inc. | → 0 | 187.809.751 $ | +1.049.751 $ | +0,6 % | 1 | ||||||||||||||
| SOLENO THERAPEUTICS INC | SLNO | → 0 | 77.004.000 $ | -57.266.000 $ | -42,6 % | 1 | 134.270.000 $ | -39.987.725 $ | -22,9 % | 1 | 174.257.725 $ | +2.508.725 $ | +1,5 % | 1 | |||||
| Taysha Gene Therapies, Inc. | TSHA | → 0 | Neutral | 162.683.327 $ | +65.684.327 $ | +67,7 % | 1 | 96.999.000 $ | -22.351.000 $ | -18,7 % | 1 | 119.350.000 $ | +48.391.000 $ | +68,2 % | 1 | 70.959.000 $ | +20.832.000 $ | +41,6 % | 1 |
| OCULAR THERAPEUTIX, INC | OCUL | → 0 | Schwach | 123.142.800 $ | +18.834.750 $ | +18,1 % | 1 | 104.308.050 $ | -26.534.163 $ | -20,3 % | 1 | 130.842.213 $ | +11.019.713 $ | +9,2 % | 1 | 119.822.500 $ | +51.150.500 $ | +74,5 % | 1 |
| Tourmaline Bio, Inc. | TRML | → 0 | 122.232.196 $ | +81.368.872 $ | +199,1 % | 1 | |||||||||||||
| AMICUS THERAPEUTICS, INC. | FOLD | → 0 | 118.397.000 $ | +15.257.000 $ | +14,8 % | 1 | |||||||||||||
| Damora Therapeutics, Inc. | GLTO | → 0 | 98.395.830 $ | +416.130 $ | +0,4 % | 1 | 97.979.700 $ | +97.979.700 $ | 1 | ||||||||||
| 89bio, Inc. | → 0 | 93.900.513 $ | +27.615.513 $ | +41,7 % | 1 | ||||||||||||||
| Hemab Therapeutics Holdings, Inc. | COAG | → 0 | Sehr schwach | 70.710.760 $ | +70.710.760 $ | 1 | |||||||||||||
| Alkermes plc. | ALKS | → 0 | Stark | 42.432.000 $ | +3.260.000 $ | +8,3 % | 1 | 39.172.000 $ | -28.028.000 $ | -41,7 % | 1 | 67.200.000 $ | -15.769.000 $ | -19,0 % | 1 | ||||
| PTC THERAPEUTICS, INC. | PTCT | → 0 | Stark | 52.032.600 $ | +52.032.600 $ | 1 | |||||||||||||
| GH Research PLC | GHRS | → 0 | Neutral | 48.384.000 $ | +23.076.000 $ | +91,2 % | 1 | 25.308.000 $ | +2.448.000 $ | +10,7 % | 1 | 22.860.000 $ | +22.860.000 $ | 1 | |||||
| Viridian Therapeutics, Inc.\DE | VRDN | → 0 | Schwach | 45.925.000 $ | +16.585.000 $ | +56,5 % | 1 | 29.340.000 $ | -17.340.000 $ | -37,1 % | 1 | 46.680.000 $ | +46.680.000 $ | 1 | |||||
| Septerna, Inc. | SEPN | → 0 | Neutral | 44.792.875 $ | +12.652.750 $ | +39,4 % | 1 | 32.140.125 $ | -5.149.375 $ | -13,8 % | 1 | 37.289.500 $ | +12.131.125 $ | +48,2 % | 1 | 25.158.375 $ | +12.078.000 $ | +92,3 % | 1 |
| Avalo Therapeutics, Inc. | AVTX | → 0 | Schwach | 43.119.994 $ | +22.068.694 $ | +104,8 % | 1 | 21.051.300 $ | +21.051.300 $ | 1 | |||||||||
| Oruka Therapeutics, Inc. | ORKA | → 0 | Neutral | 40.413.535 $ | +14.773.407 $ | +57,6 % | 1 | 25.640.128 $ | +25.640.128 $ | 1 | |||||||||
| Apogee Therapeutics, Inc. | APGE | → 0 | 37.740.000 $ | +37.740.000 $ | 1 | ||||||||||||||
| Faeth Therapeutics, Inc. | SNSE | → 0 | 36.100.975 $ | +36.100.975 $ | 1 | ||||||||||||||
| Lexeo Therapeutics, Inc. | LXEO | → 0 | Neutral | 6.932.175 $ | -3.830.325 $ | -35,6 % | 1 | 10.762.500 $ | -22.006.500 $ | -67,2 % | 1 | 32.769.000 $ | +32.769.000 $ | 1 | |||||
| MANNKIND CORP | MNKD | → 0 | Neutral | 5.390.000 $ | -19.809.997 $ | -78,6 % | 1 | 25.199.997 $ | +1.202.128 $ | +5,0 % | 1 | 23.997.869 $ | +2.118.869 $ | +9,7 % | 1 | ||||
| MoonLake Immunotherapeutics | MLTX | → 0 | Neutral | 14.340.000 $ | -181.540.000 $ | -92,7 % | 1 | ||||||||||||
| INCYTE CORP | INCY | → 0 | Stark | 13.333.950 $ | +13.333.950 $ | 1 | |||||||||||||
| Whitehawk Therapeutics, Inc. | WHWK | → 0 | Neutral | 13.050.261 $ | +3.219.824 $ | +32,8 % | 1 | 9.830.437 $ | +2.934.884 $ | +42,6 % | 1 | 6.895.553 $ | +1.481.689 $ | +27,4 % | 1 | 5.413.864 $ | +85.482 $ | +1,6 % | 1 |
| BIOCRYST PHARMACEUTICALS INC | BCRX | → 0 | Sehr stark | 9.487.500 $ | -30.832.500 $ | -76,5 % | 1 | ||||||||||||
| Tango Therapeutics, Inc. | TNGX | → 0 | Schwach | 4.578.000 $ | +4.578.000 $ | 1 | |||||||||||||
| 11.136.250.185 $ | +2.342.245.194 $ | +50,3 % | 26 | 10.164.789.055 $ | +783.454.858 $ | +0,2 % | 30 | 9.918.323.432 $ | +3.066.093.722 $ | +34,3 % | 32 | 7.736.501.045 $ | +2.103.089.588 $ | +57,0 % | 30 | ||||